Clinical Trial Update: Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing paclitaxel alone versus paclitaxel plus cetuximab in recurrent/metastatic head and neck cancer after failure of first-line chemotherapy;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | Conditions: Head and Neck Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-12-09